{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:28:40Z","timestamp":1791584920773,"version":"4.3.4"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Korean government","award":["No. RS-2025-02214844"],"award-info":[{"award-number":["No. RS-2025-02214844"]}]},{"name":"Korean government","award":["No. NRF-2022R1A2C1091055"],"award-info":[{"award-number":["No. NRF-2022R1A2C1091055"]}]},{"name":"Gangnam Severance Hospital"},{"DOI":"10.13039\/501100008005","name":"Yonsei University College of Medicine","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008005","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2025,7,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic kidney disease (CKD) has a high prevalence worldwide and is typically accompanied by severe fibrosis. However, the exact pathogenesis of renal fibrosis and effective treatments have yet to be identified. In this study, we found that expression of the histone-acetyltransferase p300 was increased in focal segmental glomerulosclerosis patients and several distinct mouse models of renal fibrosis. Moreover, we showed that the AKT-mediated phosphorylation of Ser-1834 of p300 increased the stability of p300 upon renal fibrosis induction, and conversely, PPM1K specifically dephosphorylated p300 at Ser-1834, resulting in a significant reduction in p300 stability and renal fibrosis. Interestingly, increased p300 in proximal tubular cells (PTCs) promoted renal fibrosis development by mediating the endothelial to mesenchymal transition (EndMT) via upregulation of the mesenchymal-transition-related secreted proteins POSTN, FSTL1, and FSCN1. Both EndMT and renal fibrosis were significantly diminished by either PTC-specific deletion of p300 gene or selective inhibitors of p300. Collectively, our results demonstrate the role of p300 in the development of renal fibrosis, and suggest that p300 is a promising target for treatment of advanced CKD.<\/jats:p>","DOI":"10.1038\/s44321-025-00243-1","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T20:02:11Z","timestamp":1751313731000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Loss of p300 in proximal tubular cells reduces renal fibrosis and endothelial-mesenchymal transition"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9873-9537","authenticated-orcid":false,"given":"Hyunsik","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3743-9554","authenticated-orcid":false,"given":"Soo-Yeon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2434-7917","authenticated-orcid":false,"given":"Soo Yeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hwan","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1178-7163","authenticated-orcid":false,"given":"Seunghee","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byounghwi","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Yoon","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5732-2583","authenticated-orcid":false,"given":"Beom Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2856-0133","authenticated-orcid":false,"given":"Beom Jin","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2718-3372","authenticated-orcid":false,"given":"Ho-Geun","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"243_CR1","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1159\/000516371","volume":"7","author":"M Adamczak","year":"2021","unstructured":"Adamczak M, Surma S (2021) Metabolic acidosis in patients with CKD: epidemiology, pathogenesis, and treatment. Kidney Dis 7:452\u2013467","journal-title":"Kidney Dis"},{"key":"243_CR2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41581-018-0001-y","volume":"14","author":"HJ Anders","year":"2018","unstructured":"Anders HJ, Huber TB, Isermann B, Schiffer M (2018) CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease. Nat Rev Nephrol 14:361\u2013377","journal-title":"Nat Rev Nephrol"},{"key":"243_CR3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/kisup.2014.9","volume":"4","author":"BJ Ballermann","year":"2014","unstructured":"Ballermann BJ, Obeidat M (2014) Tipping the balance from angiogenesis to fibrosis in CKD. Kidney Int Suppl ((2011)) 4:45\u201352","journal-title":"Kidney Int Suppl ((2011))"},{"key":"243_CR4","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00281-016-0559-z","volume":"38","author":"LA Borthwick","year":"2016","unstructured":"Borthwick LA (2016) The IL-1 cytokine family and its role in inflammation and fibrosis in the lung. Semin Immunopathol 38:517\u2013534","journal-title":"Semin Immunopathol"},{"key":"243_CR5","volume":"13","author":"X Cao","year":"2022","unstructured":"Cao X, Wang J, Zhang T, Liu Z, Liu L, Chen Y, Li Z, Zhao Y, Yu Q, Liu T et al (2022) Chromatin accessibility dynamics dictate renal tubular epithelial cell response to injury. Nat Commun 13:7322","journal-title":"Nat Commun"},{"key":"243_CR6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00441-011-1227-1","volume":"347","author":"RM Carew","year":"2012","unstructured":"Carew RM, Wang B, Kantharidis P (2012) The role of EMT in renal fibrosis. Cell Tissue Res 347:103\u2013116","journal-title":"Cell Tissue Res"},{"key":"243_CR7","volume":"13","author":"A Cho","year":"2023","unstructured":"Cho A, Jin W, Lee J, Shin N, Lee MS, Li L, Yang SH, Park KS, Yang CW, Kim DK et al (2023) Periostin deficiency attenuates kidney fibrosis in diabetic nephropathy by improving pancreatic beta-cell dysfunction and reducing kidney EMT. Sci Rep 13:17599","journal-title":"Sci Rep"},{"key":"243_CR8","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.103014","volume":"21","author":"M de Cos","year":"2022","unstructured":"de Cos M, Xipell M, Garcia-Herrera A, Lledo GM, Guillen E, Blasco M, Espinosa G, Cervera R, Quintana LF (2022) Assessing and counteracting fibrosis is a cornerstone of the treatment of CKD secondary to systemic and renal limited autoimmune disorders. Autoimmun Rev 21:103014","journal-title":"Autoimmun Rev"},{"key":"243_CR9","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.drudis.2009.06.008","volume":"14","author":"FJ Dekker","year":"2009","unstructured":"Dekker FJ, Haisma HJ (2009) Histone acetyl transferases as emerging drug targets. Drug Discov Today 14:942\u2013948","journal-title":"Drug Discov Today"},{"key":"243_CR10","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2022.100435","volume":"4","author":"P Devarajan","year":"2022","unstructured":"Devarajan P, Chertow GM, Susztak K, Levin A, Agarwal R, Stenvinkel P, Chapman AB, Warady BA (2022) Emerging role of clinical genetics in CKD. Kidney Med 4:100435","journal-title":"Kidney Med"},{"key":"243_CR11","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-022-02714-8","volume":"22","author":"S Dorafshan","year":"2022","unstructured":"Dorafshan S, Razmi M, Safaei S, Gentilin E, Madjd Z, Ghods R (2022) Periostin:biology and function in cancer. Cancer Cell Int 22:315","journal-title":"Cancer Cell Int"},{"key":"243_CR12","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1053\/j.gastro.2018.02.015","volume":"154","author":"C Dou","year":"2018","unstructured":"Dou C, Liu Z, Tu K, Zhang H, Chen C, Yaqoob U, Wang Y, Wen J, van Deursen J, Sicard D et al (2018) P300 acetyltransferase mediates stiffness-induced activation of hepatic stellate cells into tumor-promoting myofibroblasts. Gastroenterology 154:2209\u20132221.e2214","journal-title":"Gastroenterology"},{"key":"243_CR13","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.2337\/db19-0204","volume":"68","author":"Y Fan","year":"2019","unstructured":"Fan Y, Yi Z, D\u2019Agati VD, Sun Z, Zhong F, Zhang W, Wen J, Zhou T, Li Z, He L et al (2019) Comparison of kidney transcriptomic profiles of early and advanced diabetic nephropathy reveals potential new mechanisms for disease progression. Diabetes 68:2301\u20132314","journal-title":"Diabetes"},{"key":"243_CR14","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.cnur.2018.07.002","volume":"53","author":"AJ Flagg","year":"2018","unstructured":"Flagg AJ (2018) Chronic renal therapy. Nurs Clin North Am 53:511\u2013519","journal-title":"Nurs Clin North Am"},{"key":"243_CR15","volume":"85","author":"C Gao","year":"2021","unstructured":"Gao C, Cao N, Wang Y (2021a) Metal dependent protein phosphatase PPM family in cardiac health and diseases. Cell Signal 85:110061","journal-title":"Cell Signal"},{"key":"243_CR16","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1002\/hep.31617","volume":"73","author":"J Gao","year":"2021","unstructured":"Gao J, Wei B, Liu M, Hirsova P, Sehrawat TS, Cao S, Hu X, Xue F, Yaqoob U, Kang N et al (2021b) Endothelial p300 promotes portal hypertension and hepatic fibrosis through C-C motif chemokine ligand 2-mediated angiocrine signaling. Hepatology 73:2468\u20132483","journal-title":"Hepatology"},{"key":"243_CR17","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/jcb.24820","volume":"115","author":"AK Ghosh","year":"2014","unstructured":"Ghosh AK (2014) FAT-free p300 is good for scar-free tissue repair. J Cell Biochem 115:1486\u20131489","journal-title":"J Cell Biochem"},{"key":"243_CR18","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/jid.2012.479","volume":"133","author":"AK Ghosh","year":"2013","unstructured":"Ghosh AK, Bhattacharyya S, Lafyatis R, Farina G, Yu J, Thimmapaya B, Wei J, Varga J (2013) p300 is elevated in systemic sclerosis and its expression is positively regulated by TGF-beta:epigenetic feed-forward amplification of fibrosis. J Invest Dermatol 133:1302\u20131310","journal-title":"J Invest Dermatol"},{"key":"243_CR19","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/jcp.21162","volume":"213","author":"AK Ghosh","year":"2007","unstructured":"Ghosh AK, Varga J (2007) The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosis. J Cell Physiol 213:663\u2013671","journal-title":"J Cell Physiol"},{"key":"243_CR20","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.2741\/e480","volume":"4","author":"AK Ghosh","year":"2012","unstructured":"Ghosh AK, Vaughan DE (2012) Fibrosis:is it a coactivator disease?. Front Biosci (Elite Ed) 4:1556\u20131570","journal-title":"Front Biosci (Elite Ed)"},{"key":"243_CR21","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0168-9525(98)01438-3","volume":"14","author":"RH Giles","year":"1998","unstructured":"Giles RH, Peters DJ, Breuning MH (1998) Conjunction dysfunction:CBP\/p300 in human disease. Trends Genet 14:178\u2013183","journal-title":"Trends Genet"},{"key":"243_CR22","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110407","volume":"98","author":"Y Gong","year":"2022","unstructured":"Gong Y, Dou Y, Wang L, Wang X, Zhao Z (2022) EP300 promotes renal tubular epithelial cell fibrosis by increasing HIF2alpha expression in diabetic nephropathy. Cell Signal 98:110407","journal-title":"Cell Signal"},{"key":"243_CR23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00467-011-1772-6","volume":"27","author":"I Grgic","year":"2012","unstructured":"Grgic I, Duffield JS, Humphreys BD (2012) The origin of interstitial myofibroblasts in chronic kidney disease. Pediatr Nephrol 27:183\u2013193","journal-title":"Pediatr Nephrol"},{"key":"243_CR24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/5584_2016_84","volume":"956","author":"SM Hamrahian","year":"2017","unstructured":"Hamrahian SM, Falkner B (2017) Hypertension in chronic kidney disease. Adv Exp Med Biol 956:307\u2013325","journal-title":"Adv Exp Med Biol"},{"key":"243_CR25","first-page":"e11725","volume":"12","author":"C Hillyar","year":"2020","unstructured":"Hillyar C, Rallis KS, Varghese J (2020) Advances in epigenetic cancer therapeutics. Cureus 12:e11725","journal-title":"Cureus"},{"key":"243_CR26","doi-asserted-by":"crossref","first-page":"6592","DOI":"10.1128\/MCB.25.15.6592-6602.2005","volume":"25","author":"WC Huang","year":"2005","unstructured":"Huang WC, Chen CC (2005) Akt phosphorylation of p300 at Ser-1834 is essential for its histone acetyltransferase and transcriptional activity. Mol Cell Biol 25:6592\u20136602","journal-title":"Mol Cell Biol"},{"key":"243_CR27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-physiol-022516-034227","volume":"80","author":"BD Humphreys","year":"2018","unstructured":"Humphreys BD (2018) Mechanisms of Renal Fibrosis. Annu Rev Physiol 80:309\u2013326","journal-title":"Annu Rev Physiol"},{"key":"243_CR28","doi-asserted-by":"crossref","first-page":"9795","DOI":"10.1039\/D0CC03553J","volume":"56","author":"SY Hwang","year":"2020","unstructured":"Hwang SY, Park SY, Hong JY, Lee SY, Shin JH, Na Y, Sohn MH, Yoon HG, Kwon Y (2020) Field-based rational design of p300 histone acetyltransferase inhibitor and systematic evaluation as an anti-fibrotic agent. Chem Commun 56:9795\u20139798","journal-title":"Chem Commun"},{"key":"243_CR29","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1038\/sj.onc.1207118","volume":"23","author":"NG Iyer","year":"2004","unstructured":"Iyer NG, Ozdag H, Caldas C (2004) p300\/CBP and cancer. Oncogene 23:4225\u20134231","journal-title":"Oncogene"},{"key":"243_CR30","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.7150\/jca.51253","volume":"12","author":"YY Jia","year":"2021","unstructured":"Jia YY, Yu Y, Li HJ (2021) POSTN promotes proliferation and epithelial-mesenchymal transition in renal cell carcinoma through ILK\/AKT\/mTOR pathway. J Cancer 12:4183\u20134195","journal-title":"J Cancer"},{"key":"243_CR31","first-page":"789","volume":"35","author":"T Jin","year":"2020","unstructured":"Jin T, Zhang Y, Zhang T (2020) MiR-524-5p suppresses migration, invasion, and EMT progression in breast cancer cells through targeting FSTL1. Cancer Biother Radiopharm 35:789\u2013801","journal-title":"Cancer Biother Radiopharm"},{"key":"243_CR32","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107622","volume":"215","author":"R Kamada","year":"2020","unstructured":"Kamada R, Kudoh F, Ito S, Tani I, Janairo JIB, Omichinski JG, Sakaguchi K (2020) Metal-dependent Ser\/Thr protein phosphatase PPM family:Evolution, structures, diseases and inhibitors. Pharmacol Ther 215:107622","journal-title":"Pharmacol Ther"},{"key":"243_CR33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3762","volume":"21","author":"HM Kang","year":"2015","unstructured":"Kang HM, Ahn SH, Choi P, Ko YA, Han SH, Chinga F, Park AS, Tao J, Sharma K, Pullman J et al (2015) Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat Med 21:37\u201346","journal-title":"Nat Med"},{"key":"243_CR34","doi-asserted-by":"crossref","first-page":"114","DOI":"10.5483\/BMBRep.2022-0188","volume":"56","author":"H Kim","year":"2023","unstructured":"Kim H, Park SY, Lee SY, Kwon JH, Byun S, Kim MJ, Yu S, Yoo JY, Yoon HG (2023) Therapeutic effects of selective p300 histone acetyl-transferase inhibitor on liver fibrosis. BMB Rep 56:114\u2013119","journal-title":"BMB Rep"},{"key":"243_CR35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","volume":"12","author":"CP Kovesdy","year":"2022","unstructured":"Kovesdy CP (2022) Epidemiology of chronic kidney disease:an update 2022. Kidney Int Suppl ((2011)) 12:7\u201311","journal-title":"Kidney Int Suppl ((2011))"},{"key":"243_CR36","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/nm.3218","volume":"19","author":"VS LeBleu","year":"2013","unstructured":"LeBleu VS, Taduri G, O\u2019Connell J, Teng Y, Cooke VG, Woda C, Sugimoto H, Kalluri R (2013) Origin and function of myofibroblasts in kidney fibrosis. Nat Med 19:1047\u20131053","journal-title":"Nat Med"},{"key":"243_CR37","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1038\/s12276-023-01066-1","volume":"55","author":"SY Lee","year":"2023","unstructured":"Lee SY, Park SY, Lee SH, Kim H, Kwon JH, Yoo JY, Kim K, Park MS, Lee CG, Elias JA et al (2023) The deubiquitinase UCHL3 mediates p300-dependent chemokine signaling in alveolar type II cells to promote pulmonary fibrosis. Exp Mol Med 55:1795\u20131805","journal-title":"Exp Mol Med"},{"key":"243_CR38","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1159\/000493622","volume":"49","author":"J Li","year":"2018","unstructured":"Li J, Zhang S, Pei M, Wu L, Liu Y, Li H, Lu J, Li X (2018) FSCN1 promotes epithelial-mesenchymal transition through increasing Snail1 in ovarian cancer cells. Cell Physiol Biochem 49:1766\u20131777","journal-title":"Cell Physiol Biochem"},{"key":"243_CR39","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41581-022-00590-z","volume":"18","author":"L Li","year":"2022","unstructured":"Li L, Fu H, Liu Y (2022) The fibrogenic niche in kidney fibrosis:components and mechanisms. Nat Rev Nephrol 18:545\u2013557","journal-title":"Nat Rev Nephrol"},{"key":"243_CR40","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3389\/fphar.2019.00348","volume":"10","author":"S Li","year":"2019","unstructured":"Li S, Yu L, He A, Liu Q (2019) Klotho inhibits unilateral ureteral obstruction-induced endothelial-to-mesenchymal transition via TGF-beta1\/Smad2\/Snail1 signaling in mice. Front Pharmacol 10:348","journal-title":"Front Pharmacol"},{"key":"243_CR41","volume":"14","author":"T Li","year":"2023","unstructured":"Li T, Zhao L, Li Y, Dang M, Lu J, Lu Z, Huang Q, Yang Y, Feng Y, Wang X et al (2023) PPM1K mediates metabolic disorder of branched-chain amino acid and regulates cerebral ischemia-reperfusion injury by activating ferroptosis in neurons. Cell Death Dis 14:634","journal-title":"Cell Death Dis"},{"key":"243_CR42","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/aps.2011.111","volume":"32","author":"YG Lian","year":"2011","unstructured":"Lian YG, Zhou QG, Zhang YJ, Zheng FL (2011) VEGF ameliorates tubulointerstitial fibrosis in unilateral ureteral obstruction mice via inhibition of epithelial-mesenchymal transition. Acta Pharmacol Sin 32:1513\u20131521","journal-title":"Acta Pharmacol Sin"},{"key":"243_CR43","doi-asserted-by":"crossref","first-page":"L27","DOI":"10.1152\/ajplung.00510.2016","volume":"313","author":"T Liu","year":"2017","unstructured":"Liu T, Liu Y, Miller M, Cao L, Zhao J, Wu J, Wang J, Liu L, Li S, Zou M et al (2017) Autophagy plays a role in FSTL1-induced epithelial mesenchymal transition and airway remodeling in asthma. Am J Physiol Lung Cell Mol Physiol 313:L27\u2013L40","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"243_CR44","volume":"2022","author":"Y Liu","year":"2022","unstructured":"Liu Y, Wang J (2022) Ferroptosis, a rising force against renal fibrosis. Oxid Med Cell Longev 2022:7686956","journal-title":"Oxid Med Cell Longev"},{"key":"243_CR45","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3390\/cells4040631","volume":"4","author":"I Loeffler","year":"2015","unstructured":"Loeffler I, Wolf G (2015) Epithelial-to-mesenchymal transition in diabetic nephropathy:fact or fiction?. Cells 4:631\u2013652","journal-title":"Cells"},{"key":"243_CR46","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1111\/ajt.15340","volume":"19","author":"K Louis","year":"2019","unstructured":"Louis K, Hertig A, Taupin JL, Buob D, Jamme M, Brocheriou I, Luque Y, Jouanneau C, Ouali N, Audouin M et al (2019) Markers of graft microvascular endothelial injury may identify harmful donor-specific anti-HLA antibodies and predict kidney allograft loss. Am J Transplant 19:2434\u20132445","journal-title":"Am J Transplant"},{"key":"243_CR47","doi-asserted-by":"crossref","first-page":"eaaz2597","DOI":"10.1126\/scisignal.aaz2597","volume":"13","author":"S Lovisa","year":"2020","unstructured":"Lovisa S, Fletcher-Sananikone E, Sugimoto H, Hensel J, Lahiri S, Hertig A, Taduri G, Lawson E, Dewar R, Revuelta I et al (2020) Endothelial-to-mesenchymal transition compromises vascular integrity to induce Myc-mediated metabolic reprogramming in kidney fibrosis. Sci Signal 13:eaaz2597","journal-title":"Sci Signal"},{"key":"243_CR48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-981-13-8871-2_1","volume":"1165","author":"JC Lv","year":"2019","unstructured":"Lv JC, Zhang LX (2019) Prevalence and disease burden of chronic kidney disease. Adv Exp Med Biol 1165:3\u201315","journal-title":"Adv Exp Med Biol"},{"key":"243_CR49","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1681\/ASN.2021101293","volume":"33","author":"F Maremonti","year":"2022","unstructured":"Maremonti F, Meyer C, Linkermann A (2022) Mechanisms and models of kidney tubular necrosis and nephron loss. J Am Soc Nephrol 33:472\u2013486","journal-title":"J Am Soc Nephrol"},{"key":"243_CR50","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","volume":"12","author":"XM Meng","year":"2016","unstructured":"Meng XM, Nikolic-Paterson DJ, Lan HY (2016) TGF-beta:the master regulator of fibrosis. Nat Rev Nephrol 12:325\u2013338","journal-title":"Nat Rev Nephrol"},{"key":"243_CR51","volume":"89","author":"L Mu","year":"2023","unstructured":"Mu L, Ye Z, Hu J, Zhang Y, Chen K, Sun H, Li R, Mao W, Long X, Zhang C et al (2023) PPM1K-regulated impaired catabolism of branched-chain amino acids orchestrates polycystic ovary syndrome. EBioMedicine 89:104492","journal-title":"EBioMedicine"},{"key":"243_CR52","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/aps.2014.54","volume":"35","author":"J Ni","year":"2014","unstructured":"Ni J, Shen Y, Wang Z, Shao DC, Liu J, Kong YL, Fu LJ, Zhou L, Xue H, Huang Y et al (2014) P300-dependent STAT3 acetylation is necessary for angiotensin II-induced pro-fibrotic responses in renal tubular epithelial cells. Acta Pharmacol Sin 35:1157\u20131166","journal-title":"Acta Pharmacol Sin"},{"key":"243_CR53","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1242\/dev.127175","volume":"143","author":"LL O\u2019Brien","year":"2016","unstructured":"O\u2019Brien LL, Guo Q, Lee Y, Tran T, Benazet JD, Whitney PH, Valouev A, McMahon AP (2016) Differential regulation of mouse and human nephron progenitors by the Six family of transcriptional regulators. Development 143:595\u2013608","journal-title":"Development"},{"key":"243_CR54","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3390\/ijms22010408","volume":"22","author":"S Panizo","year":"2021","unstructured":"Panizo S, Martinez-Arias L, Alonso-Montes C, Cannata P, Martin-Carro B, Fernandez-Martin JL, Naves-Diaz M, Carrillo-Lopez N, Cannata-Andia JB (2021) Fibrosis in chronic kidney disease:pathogenesis and consequences. Int J Mol Sci 22:408","journal-title":"Int J Mol Sci"},{"key":"243_CR55","volume":"7","author":"SY Park","year":"2017","unstructured":"Park SY, Seo J, Choi HK, Oh HJ, Guk G, Lee YH, Lee J, Jun WJ, Choi KC, Yoon HG (2017) Protein serine\/threonine phosphatase PPEF-1 suppresses genotoxic stress response via dephosphorylation of PDCD5. Sci Rep 7:39222","journal-title":"Sci Rep"},{"key":"243_CR56","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.3390\/ijms22094971","volume":"22","author":"E Pontemezzo","year":"2021","unstructured":"Pontemezzo E, Foglio E, Vernucci E, Magenta A, D\u2019Agostino M, Sileno S, Astanina E, Bussolino F, Pellegrini L, Germani A et al (2021) miR-200c-3p regulates epitelial-to-mesenchymal transition in epicardial mesothelial cells by targeting epicardial follistatin-related protein 1. Int J Mol Sci 22:4971","journal-title":"Int J Mol Sci"},{"key":"243_CR57","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1111\/jcmm.14162","volume":"23","author":"R Rai","year":"2019","unstructured":"Rai R, Sun T, Ramirez V, Lux E, Eren M, Vaughan DE, Ghosh AK (2019) Acetyltransferase p300 inhibitor reverses hypertension-induced cardiac fibrosis. J Cell Mol Med 23:3026\u20133031","journal-title":"J Cell Mol Med"},{"key":"243_CR58","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1053\/j.ajkd.2015.06.028","volume":"66","author":"AB Reiss","year":"2015","unstructured":"Reiss AB, Voloshyna I, De Leon J, Miyawaki N, Mattana J (2015) Cholesterol metabolism in CKD. Am J Kidney Dis 66:1071\u20131082","journal-title":"Am J Kidney Dis"},{"key":"243_CR59","doi-asserted-by":"crossref","first-page":"12302","DOI":"10.3390\/ijms241512302","volume":"24","author":"K Rubio","year":"2023","unstructured":"Rubio K, Molina-Herrera A, Perez-Gonzalez A, Hernandez-Galdamez HV, Pina-Vazquez C, Araujo-Ramos T, Singh I (2023) EP300 as a molecular integrator of fibrotic transcriptional programs. Int J Mol Sci 24:12302","journal-title":"Int J Mol Sci"},{"key":"243_CR60","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1053\/j.ajkd.2021.11.010","volume":"80","author":"M Ruiz-Ortega","year":"2022","unstructured":"Ruiz-Ortega M, Lamas S, Ortiz A (2022) Antifibrotic agents for the management of CKD:a review. Am J Kidney Dis 80:251\u2013263","journal-title":"Am J Kidney Dis"},{"key":"243_CR61","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41581-023-00694-0","volume":"19","author":"AB Sanz","year":"2023","unstructured":"Sanz AB, Sanchez-Nino MD, Ramos AM, Ortiz A (2023) Regulated cell death pathways in kidney disease. Nat Rev Nephrol 19:281\u2013299","journal-title":"Nat Rev Nephrol"},{"key":"243_CR62","doi-asserted-by":"crossref","first-page":"21087","DOI":"10.3390\/ijms141021087","volume":"14","author":"S Sarkar","year":"2013","unstructured":"Sarkar S, Horn G, Moulton K, Oza A, Byler S, Kokolus S, Longacre M (2013) Cancer development, progression, and therapy:an epigenetic overview. Int J Mol Sci 14:21087\u201321113","journal-title":"Int J Mol Sci"},{"key":"243_CR63","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.3390\/jcm11185368","volume":"11","author":"M Sisto","year":"2022","unstructured":"Sisto M, Ribatti D, Ingravallo G, Lisi S (2022) The expression of follistatin-like 1 protein is associated with the activation of the EMT program in Sjogren\u2019s syndrome. J Clin Med 11:5368","journal-title":"J Clin Med"},{"key":"243_CR64","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.diff.2016.05.008","volume":"92","author":"YB Sun","year":"2016","unstructured":"Sun YB, Qu X, Caruana G, Li J (2016) The origin of renal fibroblasts\/myofibroblasts and the signals that trigger fibrosis. Differentiation 92:102\u2013107","journal-title":"Differentiation"},{"key":"243_CR65","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.3389\/fimmu.2019.01525","volume":"10","author":"AEA Surace","year":"2019","unstructured":"Surace AEA, Hedrich CM (2019) The role of epigenetics in autoimmune\/inflammatory disease. Front Immunol 10:1525","journal-title":"Front Immunol"},{"key":"243_CR66","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/PL00000896","volume":"58","author":"S Timmermann","year":"2001","unstructured":"Timmermann S, Lehrmann H, Polesskaya A, Harel-Bellan A (2001) Histone acetylation and disease. Cell Mol Life Sci 58:728\u2013736","journal-title":"Cell Mol Life Sci"},{"key":"243_CR67","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1053\/j.ackd.2011.07.001","volume":"18","author":"VM Vehaskari","year":"2011","unstructured":"Vehaskari VM (2011) Genetics and CKD. Adv Chronic Kidney Dis 18:317\u2013323","journal-title":"Adv Chronic Kidney Dis"},{"key":"243_CR68","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/MNH.0000000000000627","volume":"29","author":"TJ Wilkinson","year":"2020","unstructured":"Wilkinson TJ, McAdams-DeMarco M, Bennett PN, Wilund K, Global Renal Exercise N (2020) Advances in exercise therapy in predialysis chronic kidney disease, hemodialysis, peritoneal dialysis, and kidney transplantation. Curr Opin Nephrol Hypertens 29:471\u2013479","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"243_CR69","doi-asserted-by":"crossref","unstructured":"Wu M, Hao Y, Wu X, Zhu M, Chen X, Qi J, Yu Z, Xu H (2024) SirT7-mediated transcription of fascin in hyperglycemic glomerular endothelial cells contributes to EndMT in diabetic nephropathy. Acta Biochim Biophys Sinica 56:586\u2013596","DOI":"10.3724\/abbs.2024002"},{"key":"243_CR70","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","volume":"214","author":"TA Wynn","year":"2008","unstructured":"Wynn TA (2008) Cellular and molecular mechanisms of fibrosis. J Pathol 214:199\u2013210","journal-title":"J Pathol"},{"key":"243_CR71","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","volume":"18","author":"TA Wynn","year":"2012","unstructured":"Wynn TA, Ramalingam TR (2012) Mechanisms of fibrosis:therapeutic translation for fibrotic disease. Nat Med 18:1028\u20131040","journal-title":"Nat Med"},{"key":"243_CR72","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1111\/ajt.15847","volume":"20","author":"YC Xu-Dubois","year":"2020","unstructured":"Xu-Dubois YC, Ahmadpoor P, Brocheriou I, Louis K, Arzouk Snanoudj N, Rouvier P, Taupin JL, Corchia A, Galichon P, Barrou B et al (2020) Microvasculature partial endothelial mesenchymal transition in early posttransplant biopsy with acute tubular necrosis identifies poor recovery renal allografts. Am J Transplant 20:2400\u20132412","journal-title":"Am J Transplant"},{"key":"243_CR73","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1681\/ASN.2014070679","volume":"27","author":"YC Xu-Dubois","year":"2016","unstructured":"Xu-Dubois YC, Peltier J, Brocheriou I, Suberbielle-Boissel C, Djamali A, Reese S, Mooney N, Keuylian Z, Lion J, Ouali N et al (2016) Markers of endothelial-to-mesenchymal transition:evidence for antibody-endothelium interaction during antibody-mediated rejection in kidney recipients. J Am Soc Nephrol 27:324\u2013332","journal-title":"J Am Soc Nephrol"},{"key":"243_CR74","volume":"173","author":"T Xue","year":"2021","unstructured":"Xue T, Qiu X, Liu H, Gan C, Tan Z, Xie Y, Wang Y, Ye T (2021) Epigenetic regulation in fibrosis progress. Pharmacol Res 173:105910","journal-title":"Pharmacol Res"},{"key":"243_CR75","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tem.2023.09.001","volume":"35","author":"N Yamashita","year":"2024","unstructured":"Yamashita N, Kramann R (2024) Mechanisms of kidney fibrosis and routes towards therapy. Trends Endocrinol Metab 35:31\u201348","journal-title":"Trends Endocrinol Metab"},{"key":"243_CR76","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/978-981-13-8871-2_12","volume":"1165","author":"Q Yuan","year":"2019","unstructured":"Yuan Q, Tan RJ, Liu Y (2019) Myofibroblast in kidney fibrosis:origin, activation, and regulation. Adv Exp Med Biol 1165:253\u2013283","journal-title":"Adv Exp Med Biol"},{"key":"243_CR77","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1681\/ASN.2008050513","volume":"19","author":"EM Zeisberg","year":"2008","unstructured":"Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, Kalluri R (2008) Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 19:2282\u20132287","journal-title":"J Am Soc Nephrol"},{"key":"243_CR78","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-981-15-3449-2_1","volume":"1253","author":"L Zhang","year":"2020","unstructured":"Zhang L, Lu Q, Chang C (2020) Epigenetics in health and disease. Adv Exp Med Biol 1253:3\u201355","journal-title":"Adv Exp Med Biol"},{"key":"243_CR79","volume":"13","author":"L Zhang","year":"2022","unstructured":"Zhang L, Sang X, Han Y, Abulitibu A, Elken M, Mao Z, Kang S, Yang W, Lu C (2022) The expression of apoptosis related genes in HK-2 cells overexpressing PPM1K was determined by RNA-seq analysis. Front Genet 13:1004610","journal-title":"Front Genet"},{"key":"243_CR80","volume":"12","author":"WJ Zhang","year":"2021","unstructured":"Zhang WJ, Chen SJ, Zhou SC, Wu SZ, Wang H (2021) Inflammasomes and Fibrosis. Front Immunol 12:643149","journal-title":"Front Immunol"},{"key":"243_CR81","first-page":"1455","volume":"52","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Lu Y, Zhang C, Huang D, Wu W, Zhang Y, Shen J, Cai Y, Chen W, Yao W (2018) FSCN\u20111 increases doxorubicin resistance in hepatocellular carcinoma through promotion of epithelial-mesenchymal transition. Int J Oncol 52:1455\u20131464","journal-title":"Int J Oncol"},{"key":"243_CR82","volume":"13","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Shi C, Yang Y, Hu X, Ni H, Li L, Cheng Z, Huang J, Chen P (2023) Identifying key genes related to the peritubular capillary rarefaction in renal interstitial fibrosis by bioinformatics. Sci Rep 13:19611","journal-title":"Sci Rep"},{"key":"243_CR83","doi-asserted-by":"crossref","first-page":"e152330","DOI":"10.1172\/jci.insight.152330","volume":"7","author":"X Zhao","year":"2022","unstructured":"Zhao X, Kong Y, Liang B, Xu J, Lin Y, Zhou N, Li J, Jiang B, Cheng J, Li C et al (2022) Mechanosensitive Piezo1 channels mediate renal fibrosis. JCI Insight 7:e152330","journal-title":"JCI Insight"},{"key":"243_CR84","volume":"13","author":"W Zhou","year":"2022","unstructured":"Zhou W, Wu WH, Si ZL, Liu HL, Wang H, Jiang H, Liu YF, Alolga RN, Chen C, Liu SJ et al (2022) The gut microbe Bacteroides fragilis ameliorates renal fibrosis in mice. Nat Commun 13:6081","journal-title":"Nat Commun"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00243-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-025-00243-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00243-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:49:26Z","timestamp":1786978166000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-025-00243-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":84,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7,11]]}},"alternative-id":["243"],"URL":"https:\/\/doi.org\/10.1038\/s44321-025-00243-1","relation":{},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"17 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}],"article-number":"5"}}